Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 91 to 92 of 92 results for atezolizumab

  1. New injectable immunotherapy treatment for rare form of triple negative breast cancer recommended by NICE

    People with triple negative breast cancer that has spread to other parts of the body may soon benefit from pembrolizumab in combination with chemotherapy.

  2. Avelumab not recommended as a maintenance treatment of urothelial cancer

    NICE has issued draft guidance which does not recommend avelumab for maintenance treatment of urothelial cancer after platinum-based chemotherapy.